記事

Dr. Reddy’s is improving supply chain performance for Pregabalin API through large manufacturing capacity and backward integration

The global pharmaceutical industry is currently challenged by uncertain or disrupted API supplies, which is impacting their ability to serve patient needs. At Dr. Reddy’s, we are strongly committed to de-risk the supply chain management to ideally support the API needs of our customers.

Pregabalin is one of the key APIs in Dr. Reddy’s portfolio and in our endeavour to be one of the most reliable API suppliers worldwide, Dr. Reddy’s is following a structured approach to tackle this uncertainty.  The access to one of the largest manufacturing facilities dedicated to the production of Pregabalin APIs, combined with a backward integrated supply of advanced intermediates, will give our customers the advantage of a de-risked supply chain for an on time and in full delivery.

How Dr. Reddy’s is catering to its customers’ specific needs and reducing supply management risks:

1. Extensive capacities and capabilities: With a capacity of over 180 MT, Pregabalin API is manufactured at an automated manufacturing line that uses a distributed control system. This allows tighter control over all quality parameters including particle size distribution.  This gives us the ability to cater to a wide range of customer PSD requirements - d(90) : 50 to 800 microns.

2. Backward integration and supply chain visibility: The backward integration of intermediates facilitates stable supplies with stringent quality control across the whole synthesis route. Depending on customers’ requirements, we can meet delivery lead times of less than 90 days.

3. Large batch size: Our batch size of 1000 kg economizes analytical batch testing for our customers and provides order flexibility.

How can we meet your Pregabalin API needs? Please write in to us at api@drreddys.com with your requirements or fill the enquiry form below.

Explore our Pregabalin API offering by clicking on the link below:

https://api.drreddys.com/ja/product/pregabalin

Disclaimer:

The scientific content of this article has been developed by Dr.Reddy’s Laboratories Limited (“DRL”) for educational and awareness purpose only. Although greatest possible care has been taken in compiling, checking and developing the content to ensure that it is accurate and complete, the authors, DRL, are not responsible or in any way liable for any injury or damage to any persons in view of any reliance placed on or action taken basis of the information in this article or any errors, omissions or inaccuracies and/or incompleteness of the information in this article, whether arising from negligence or otherwise. No part of the article including graphics available in this presentation may be copied or reproduced, in whole or in part, without the consent of DRL, other than for purposes permitted under fair use by copyright law.